Diabetes mellitus (DM) increases the risk of cardiovascular disease (CVD) through mechanisms involving chronic inflammation and oxidative stress. Myeloperoxidase (MPO), a heme-containing enzyme catalyses the formation of reactive oxygen species (ROS). This study investigated the prognostic value of serum MPO in dia...
H. Shokr, Yasser Abdelmohaimen, Dumindri Abeysena et al.· Scientific Reports· 0 citations
The serum levels of complement hs-CRP, C3d, and MBL were compared among the three groups to investigate the connections between microvascular complications (DMCs) and serum complement hs-CRP, C3d, and MBL levels in individuals with type 2 diabetes mellitus (T2DM).
Ping Huang, Zixuan Tang, Yanyan Liu et al.· 0 citations
The atherogenic index of plasma (AIP) is a lipid‐based indicator of cardiometabolic risk. We examined whether AIP is associated with prevalent type 2 diabetes mellitus (T2DM) and fasting blood sugar (FBS) in patients with premature coronary artery disease (PCAD) and explored whether this association differed across Ira...
Raza Amani-Beni, G. Dabaghi, N. Mohammadifard et al.· Endocrinology, Diabetes & Me...· 0 citations
Type 1 diabetes mellitus (T1DM) is an autoimmune disease marked by irreversible loss of pancreatic β -cells, which ultimately causes insulin deficiency and hyperglycemia. As of 2022, the global prevalence reached 8.75 million cases [1]. T1DM demonstrates a rising global incidence [2] and marked autoimmune comorbidity (...
Hui Zhao, Yu Wang, Zou-Xi Du et al.· Archives of Medical Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.